Journal of Molecular and Cellular Cardiology
Volume 48, Issue 5 , Pages 810-816 , May 2010

Why does troponin I have so many phosphorylation sites? Fact and fancy

  • R. John Solaro

      Affiliations

    • Center for Cardiovascular Research and, Department of Physiology and Biophysics, University of Illinois at Chicago, College of Medicine, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding authors. R.J. Solaro is to be contacted at Department of Physiology and Biophysics M/C 901, University of Illinois at Chicago, College of Medicine, 835 South Wolcott Avenue, Chicago, IL 60612, USA. Tel.: +1 312 996 7620; fax: +1 312 996 1414. J. van der Velden, Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, Van der Boechorstraat 7, 1081 BT Amsterdam, The Netherlands. Tel.: +31 204448113; fax: +31 204448255
    • Both authors contributed equally to this work
    • ,
  • Jolanda van der Velden

      Affiliations

    • Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, 1081 BT Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding authors. R.J. Solaro is to be contacted at Department of Physiology and Biophysics M/C 901, University of Illinois at Chicago, College of Medicine, 835 South Wolcott Avenue, Chicago, IL 60612, USA. Tel.: +1 312 996 7620; fax: +1 312 996 1414. J. van der Velden, Laboratory for Physiology, Institute for Cardiovascular Research, VU University Medical Center, Van der Boechorstraat 7, 1081 BT Amsterdam, The Netherlands. Tel.: +31 204448113; fax: +31 204448255
    • Both authors contributed equally to this work

Received 22 December 2009 ,Revised 18 February 2010 ,Accepted 18 February 2010.

References 

  1. Stull JT, Brostrom CO, Krebs EG. Phosphorylation of the inhibitor component of troponin by phosphorylase kinase. J Biol Chem. Aug 25 1972;247(16):5272–5274
  2. Pratje E, Heilmeyer LM. Phosphorylation of rabbit muscle troponin and actin by a 3′, 5′-c-AMP-dependent protein kinase. FEBS Lett. Oct 15 1972;27(1):89–93
  3. Metzger JM, Westfall MV. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ Res. Feb 6 2004;94(2):146–158
  4. Kobayashi T, Solaro RJ. Calcium, thin filaments, and the integrative biology of cardiac contractility. Annu Rev Physiol. 2005;67:39–67
  5. Solaro RJ, Moir AJ, Perry SV. Phosphorylation of troponin I and the inotropic effect of adrenaline in the perfused rabbit heart. Nature. Aug 12 1976;262(5569):615–617
  6. Moir AJ, Solaro RJ, Perry SV. The site of phosphorylation of troponin I in the perfused rabbit heart. The effect of adrenaline. Biochem J. Feb 1 1980;185(2):505–513
  7. Robertson SP, Johnson JD, Holroyde MJ, Kranias EG, Potter JD, Solaro RJ. The effect of troponin I phosphorylation on the Ca2+-binding properties of the Ca2+-regulatory site of bovine cardiac troponin. J Biol Chem. Jan 10 1982;257(1):260–263
  8. Takimoto E, Soergel DG, Janssen PM, Stull LB, Kass DA, Murphy AM. Frequency- and afterload-dependent cardiac modulation in vivo by troponin I with constitutively active protein kinase A phosphorylation sites. Circ Res. Mar 5 2004;94(4):496–504
  9. Moir AJ, Perry SV. Phosphorylation of rabbit cardiac-muscle troponin I by phosphorylase kinase. The effect of adrenaline. Biochem J. Nov 1 1980;191(2):547–554
  10. Li MX, Wang X, Lindhout DA, Buscemi N, Van Eyk JE, Sykes BD. Phosphorylation and mutation of human cardiac troponin I deferentially destabilize the interaction of the functional regions of troponin I with troponin C. Biochemistry. Dec 16 2003;42(49):14460–14468
  11. Ke Y, Wang L, Pyle WG, de Tombe PP, Solaro RJ. Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes. Circ Res. Feb 6 2004;94(2):194–200
  12. You B, Yan G, Zhang Z, Yan L, Li J, Ge Q, et al. Phosphorylation of cardiac troponin I by mammalian sterile 20-like kinase 1. Biochem J. Feb 15 2009;418(1):93–101
  13. Noland TA, Raynor RL, Jideama NM, Guo X, Kazanietz MG, Blumberg PM, et al. Differential regulation of cardiac actomyosin S-1 MgATPase by protein kinase C isozyme-specific phosphorylation of specific sites in cardiac troponin I and its phosphorylation site mutants. Biochemistry. Nov 26 1996;35(47):14923–14931
  14. Noland TA, Guo X, Raynor RL, Jideama NM, Averyhart-Fullard V, Solaro RJ, et al. Cardiac troponin I mutants. Phosphorylation by protein kinases C and A and regulation of Ca(2+)-stimulated MgATPase of reconstituted actomyosin S-1. J Biol Chem. Oct 27 1995;270(43):25445–25454
  15. Mazzei GJ, Kuo JF. Phosphorylation of skeletal-muscle troponin I and troponin T by phospholipid-sensitive Ca2+-dependent protein kinase and its inhibition by troponin C and tropomyosin. Biochem J. Mar 1 1984;218(2):361–369
  16. Noland TA, Raynor RL, Kuo JF. Identification of sites phosphorylated in bovine cardiac troponin I and troponin T by protein kinase C and comparative substrate activity of synthetic peptides containing the phosphorylation sites. J Biol Chem. Dec 5 1989;264(34):20778–20785
  17. Sumandea MP, Rybin VO, Hinken AC, Wang C, Kobayashi T, Harleton E, et al. Tyrosine phosphorylation modifies protein kinase C delta-dependent phosphorylation of cardiac troponin I. J Biol Chem. Aug 15 2008;283(33):22680–22689
  18. Mathur MC, Kobayashi T, Chalovich JM. Negative charges at protein kinase C sites of troponin I stabilize the inactive state of actin. Biophys J. Jan 15 2008;94(2):542–549
  19. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E, et al. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem. Mar 28 2003;278(13):11265–11272
  20. Wang H, Grant JE, Doede CM, Sadayappan S, Robbins J, Walker JW. PKC-betaII sensitizes cardiac myofilaments to Ca2+ by phosphorylating troponin I on threonine-144. J Mol Cell Cardiol. Nov 2006;41(5):823–833
  21. Pi Y, Zhang D, Kemnitz KR, Wang H, Walker JW. Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium. J Physiol. Nov 1 2003;552(Pt 3):845–857
  22. Pi Y, Kemnitz KR, Zhang D, Kranias EG, Walker JW. Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ Res. Apr 5 2002;90(6):649–656
  23. Goldspink PH, Montgomery DE, Walker LA, Urboniene D, McKinney RD, Geenen DL, et al. Protein kinase Cepsilon overexpression alters myofilament properties and composition during the progression of heart failure. Circ Res. Aug 20 2004;95(4):424–432
  24. Scruggs SB, Walker LA, Lyu T, Geenen DL, Solaro RJ, Buttrick PM, et al. Partial replacement of cardiac troponin I with a non-phosphorylatable mutant at serines 43/45 attenuates the contractile dysfunction associated with PKC epsilon phosphorylation. J Mol Cell Cardiol. 2006;40(4):465–473
  25. Sakthivel S, Finley NL, Rosevear PR, Lorenz JN, Gulick J, Kim S, et al. In vivo and in vitro analysis of cardiac troponin I phosphorylation. J Biol Chem. Jan 7 2005;280(1):703–714
  26. Roman BB, Goldspink PH, Spaite E, Urboniene D, McKinney R, Geenen DL, et al. Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo. Am J Physiol Heart Circ Physiol. Jun 2004;286(6):H2089–H2095
  27. Solaro RJ, de Tombe PP. Review focus series: sarcomeric proteins as key elements in integrated control of cardiac function. Cardiovasc Res. 2008;77(4):616–618
  28. Morimoto S. Sarcomeric proteins and inherited cardiomyopathies. Cardiovasc Res. Mar 1 2008;77(4):659–666
  29. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ, et al. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res. Jul 20 2007;101(2):195–204
  30. Belin RJ, Sumandea MP, Kobayashi T, Walker LA, Rundell VL, Urboniene D, et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol. Nov 2006;291(5):H2344–H2353
  31. Marston SB, de Tombe PP. Troponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: increased or decreased?. J Mol Cell Cardiol. Nov 2008;45(5):603–607
  32. Zabrouskov V, Ge Y, Schwartz J, Walker JW. Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry. Mol Cell Proteomics. Oct 2008;7(10):1838–1849
  33. Ayaz-Guner S, Zhang J, Li L, Walker JW, Ge Y. In vivo phosphorylation site mapping in mouse cardiac troponin I by high resolution top-down electron capture dissociation mass spectrometry: Ser22/23 are the only sites basally phosphorylated. Biochemistry. Jul 28 2009;48(34):8161–8170
  34. Sancho Solis R, Ge Y, Walker JW. Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top-down tandem mass spectrometry. J Muscle Res Cell Motil. 2008;29(6–8):203–212
  35. Hamdani N, de Waard M, Messer AE, Boontje NM, Kooij V, van Dijk S, et al. Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil. 2008;29(6–8):189–201
  36. Marston SB, Walker JW. Back to the future: new techniques show that forgotten phosphorylation sites are present in contractile proteins of the heart whilst intensively studied sites appear to be absent. J Muscle Res Cell Motil. 2009;30:93–95
  37. Kooij V, Boontje N, Zaremba R, Jaquet K, Dos Remedios C, Stienen GJ, et al. Protein kinase C alpha and epsilon phosphorylation of troponin and myosin binding protein C reduce Ca(2+) sensitivity in human myocardium. Basic Res Cardiol. Aug 5 2010;105(2):289–300
  38. Kaminsky M, Afari-Armah N, Dike U, Solaro RJ, Chen-Izu Y, Sumandea MP. Differential phosphorylation of cTnT, cTnI and MLC2 with heart disease progression from pre-hypertension to heart failure. Biophys J. 2005;153/PosB528:
  39. McDonough JL, Labugger R, Pickett W, Tse MY, MacKenzie S, Pang SC, et al. Cardiac troponin I is modified in the myocardium of bypass patients. Circulation. Jan 2 2001;103(1):58–64
  40. Murphy AM, Kogler H, Georgakopoulos D, McDonough JL, Kass DA, Van Eyk JE, et al. Transgenic mouse model of stunned myocardium. Science. Jan 21 2000;287(5452):488–491
  41. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM. Preload induces troponin I degradation independently of myocardial ischemia. Circulation. Apr 24 2001;103(16):2035–2037
  42. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res. Mar 1997;80(3):393–399
  43. McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ Res. Jan 8–22 1999;84(1):9–20
  44. Van Eyk JE, Powers F, Law W, Larue C, Hodges RS, Solaro RJ. Breakdown and release of myofilament proteins during ischemia and ischemia/reperfusion in rat hearts: identification of degradation products and effects on the pCa-force relation. Circ Res. Feb 9 1998;82(2):261–271
  45. Tachampa K, Kobayashi T, Wang H, Martin AF, Biesiadecki BJ, Solaro RJ, et al. Increased cross-bridge cycling kinetics after exchange of C-terminal truncated troponin I in skinned rat cardiac muscle. J Biol Chem. May 30 2008;283(22):15114–15121
  46. Narolska NA, Piroddi N, Belus A, Boontje NM, Scellini B, Deppermann S, et al. Impaired diastolic function after exchange of endogenous troponin I with C-terminal truncated troponin I in human cardiac muscle. Circ Res. Oct 27 2006;99(9):1012–1020
  47. Galinska-Rakoczy A, Engel P, Xu C, Jung H, Craig R, Tobacman LS, et al. Structural basis for the regulation of muscle contraction by troponin and tropomyosin. J Mol Biol. Jun 20 2008;379(5):929–935
  48. Galinska-Rakoczy A, Hatch V, Craig R, Murphy AM, Van Eyk JE, Wang CLA, et al. EM and 3D-reconstruction of thin filaments reconstituted with truncated troponin I. Biophys J. 2009;96:502a
  49. de Waard MC, van der Velden J, Bito V, Ozdemir S, Biesmans L, Boontje NM, et al. Early exercise training normalizes myofilament function and attenuates left ventricular pump dysfunction in mice with a large myocardial infarction. Circ Res. Apr 13 2007;100(7):1079–1088
  50. Duncker DJ, Boontje NM, Merkus D, Versteilen A, Krysiak J, Mearini G, et al. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling. Circ Heart Fail. May 2009;2(3):233–242
  51. Montgomery DE, Chandra M, Huang Q, Jin J, Solaro RJ. Transgenic incorporation of skeletal TnT into cardiac myofilaments blunts PKC-mediated depression of force. Am J Physiol Heart Circ Physiol. Mar 2001;280(3):H1011–H1018
  52. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem. Sep 12 2003;278(37):35135–35144
  53. Noguchi T, Hunlich M, Camp PC, Begin KJ, El-Zaru M, Patten R, et al. Thin-filament-based modulation of contractile performance in human heart failure. Circulation. Aug 24 2004;110(8):982–987
  54. Colantonio DA, Van Eyk JE, Przyklenk K. Stunned peri-infarct canine myocardium is characterized by degradation of troponin T, not troponin I. Cardiovasc Res. Aug 1 2004;63(2):217–225
  55. van der Velden J, Narolska NA, Lamberts RR, Boontje NM, Borbely A, Zaremba R, et al. Functional effects of protein kinase C-mediated myofilament phosphorylation in human myocardium. Cardiovasc Res. Mar 1 2006;69(4):876–887
  56. Messer AE, Jacques AM, Marston SB. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J Mol Cell Cardiol. Jan 2007;42(1):247–259
  57. Wolff MR, Buck SH, Stoker SW, Greaser ML, Mentzer RM. Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation. J Clin Invest. Jul 1 1996;98(1):167–176
  58. Walker LA, Walker JS, Ambler SK, Buttrick PM. Stage-specific changes in myofilament protein phosphorylation following myocardial infarction in mice. J Mol Cell Cardiol. Sep 30 2009;
  59. Lamberts RR, Hamdani N, Soekhoe TW, Boontje NM, Zaremba R, Walker LA, et al. Frequency-dependent myofilament Ca2+ desensitization in failing rat myocardium. J Physiol. Jul 15 2007;582(Pt 2):695–709
  60. Varian KD, Kijtawornrat A, Gupta SC, Torres CA, Monasky MM, Hiranandani N, et al. Impairment of diastolic function by lack of frequency-dependent myofilament desensitization rabbit right ventricular hypertrophy. Circ Heart Fail. Sep 2009;2(5):472–481
  61. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, van der Velden J, Stienen GJ, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. Apr 25 2006;113(16):1966–1973
  62. Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C, et al. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res. Mar 27 2009;104(6):780–786
  63. van Dijk SJ, Dooijes D, dos Remedios C, Michels M, Lamers JM, Winegrad S, et al. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation. Mar 24 2009;119(11):1473–1483
  64. Kooij V, van der Velden J, Stienen G. Effect fo troponin I Ser23/24 bis-phosphorylation on Ca-sensitivity is dependent on PKA phosphorylation of other contractile proteins. Biophys J. 2009;96:501a–502a
  65. Kirk JA, Macgowan GA, Evans C, Smith SH, Warren CM, Mamidi R, et al. Left ventricular and myocardial function in mice expressing constitutively pseudophosphorylated cardiac troponin I. Circ Res. Oct 22 2009;105(12):1232–1239
  66. Rudy Y, Ackerman MJ, Bers DM, Clancy CE, Houser SR, London B, et al. Systems approach to understanding electromechanical activity in the human heart: a national heart, lung, and blood institute workshop summary. Circulation. Sep 9 2008;118(11):1202–1211
  67. Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ, et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation. Feb 15 2005;111(6):774–781
  68. Freund C, Davis RP, Gkatzis K, Ward-van Oosterwaard D, Mummery CL. The first reported generation of human induced pluripotent stem cells (iPS cells) and iPS cell-derived cardiomyocytes in the Netherlands. Neth Heart J. Jan 2010;18(1):51–54

PII: S0022-2828(10)00075-1

doi: 10.1016/j.yjmcc.2010.02.014

Journal of Molecular and Cellular Cardiology
Volume 48, Issue 5 , Pages 810-816 , May 2010

Article Tools

* Image Usage & Resolution